Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
Swedencare Community
OM:SECARE Community
1
Narratives
written by author
0
Comments
on narratives written by author
1
Fair Values set
on narratives written by author
Create a narrative
Swedencare
Popular
Undervalued
Overvalued
Community Investing Ideas
Swedencare
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
ProDen PlaqueOff's VOHC Certification And NaturVet's Revival Will Drive Future Expansion
Key Takeaways NaturVet's growth through improved customer relations and visibility, alongside expansion in major sales channels, can drive significant revenue increase and operational scale. Strategic local manufacturing and new market acceptance enhance Swedencare's competitiveness, improve cost efficiencies, and boost investor interest, potentially positively impacting net margins and market capitalization.
View narrative
SEK 57.00
FV
37.5% undervalued
intrinsic discount
11.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
SECARE
SECARE
Swedencare
Your Fair Value
SEK
Current Price
SEK 35.60
23.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 4.2b
Earnings SEK 164.8m
Advanced
Set Fair Value